Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Emicizumab (Hemlibra°) in haemophilia A. A first-choice preventive treatment for patients with factor VIII inhibitors

In the December issue of Prescrire International: pertuzumab (Perjeta°) after surgery for some breast cancers at high risk of recurrence

The Mediator° disaster: so much time wasted, so many lives destroyed

Diclofenac: a habit that needs changing

Anti-inflammatory drugs: risks for the kidneys even in young, healthy adults

Sore throat: paracetamol is the best option

Dolutegravir + rilpivirine (Juluca°) dual therapy in HIV infection

In the November issue of Prescrire International - Gliptins: joint pain and exposure to NSAIDs

Gemtuzumab ozogamicin (Mylotarg°) in acute myeloid leukaemia: no proven benefits

Fenspiride (Pneumorel°): serious adverse effects reported over two decades

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90